NEWS AND Press Releases Stay up to date on the latest Advent news Search by topic Search by type All content types In the news Press release Search by sector All sectors Business & financial services Consumer Healthcare Industrial Technology Search by deal type All deal types Search by location All locations Australia Brazil Canada Colombia France Germany Greater China India Italy New Zealand South Africa Spain United Kingdom United States Default Sort OrderAlphabeticalNewest first Reset filters Newest first Alphabetical Results 46-54 of 66 Previous page Next page Press release Advent International to enter a partnership with the founder of the Parfums de Marly and INITIO Parfums Privés niche fragrance brands to accelerate global growth June 22, 2023 Press release Advent International agrees to partial sale of InPost shareholding to PPF Group May 26, 2023 In the news Advent International in Spain May 16, 2023 Press release Baxter signs definitive agreement to divest its BioPharma Solutions business to Advent International and Warburg Pincus for $4.25 billion May 8, 2023 Press release Sunley House Changes Name to Advent Global Opportunities April 26, 2023 Press release Envalior enters the engineering materials market as a new global leader April 3, 2023 Press release Advent International Appoints Biopharma Executive James Mullen as Operating Partner March 28, 2023 In the news Advent’s Francesco Casiraghi on creating a global speciality ingredients platform March 7, 2023 Press release Advent International agrees to sell Tag, a leading global marketing production company, to dentsu March 7, 2023 First 5678 CONTACT US We’re always evolving, and we’d love to stay in touch with you as we do Stay connected
Press release Advent International to enter a partnership with the founder of the Parfums de Marly and INITIO Parfums Privés niche fragrance brands to accelerate global growth June 22, 2023
Press release Advent International agrees to partial sale of InPost shareholding to PPF Group May 26, 2023
Press release Baxter signs definitive agreement to divest its BioPharma Solutions business to Advent International and Warburg Pincus for $4.25 billion May 8, 2023
Press release Advent International Appoints Biopharma Executive James Mullen as Operating Partner March 28, 2023
In the news Advent’s Francesco Casiraghi on creating a global speciality ingredients platform March 7, 2023
Press release Advent International agrees to sell Tag, a leading global marketing production company, to dentsu March 7, 2023
